Sangamo Biosciences Inc. (SGMO)
Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company’s product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc., formerly known as Sangamo BioSciences Inc., is based in Richmond, United States.
Sangamo Biosciences Inc. (SGMO)’s Financial Overview
Sangamo Biosciences Inc. (SGMO) surged 3.82% yesterday to close its trading session at $19.73. The company has 1 year Price Target of $29.5. The stock touched its 52-Week High on Obsolete and 52-Week Low on Obsolete. The stock traded with the volume of 5.16 Million shares yesterday. The firm shows the market capitalization of $1.73 Billion.
The firm is trading with SMA20 of -17.88 Percent, SMA50 of SMA50 Percent and SMA200 of 30.47 percent. Sangamo Biosciences Inc. has P/S value of 47.39 while its P/B value stands at 8.93. Similarly, the company has Return on Assets of -22.1 percent, Return on Equity of -31.4 percent and Return on Investment of -26.5 Percent.
The Stock currently has Analyst’ mean Recommendation of 1.9 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 5 analysts offering 12-month price forecasts for Sangamo Therapeutics Inc have a median target of 20.00, with a high estimate of 30.00 and a low estimate of 6.00. The median estimate represents a +1.39% increase from the last price of 19.73.
Goldcorp Inc. (GG)
Goldcorp has operations in Canada, the US, Mexico and Central and South America. Apart from gold, the company also produces copper and silver. The company’s principal producing mining properties are the Red Lake, Porcupine and Musselwhite gold mines in Canada The Penasquito gold/silver/zinc/lead mine, the Pueblo Viejo gold mine (40% interest) in the Dominican Republic, the Los Filos and El Sauzal gold mines in Mexico the Marlin gold/silver mine in Guatemala the Alumbrera gold/copper mine (37.5% interest) in Argentina and the Marigold (66.7% interest) and Wharf gold mines in the United States. Goldcorp has significant development projects which include the Cerro Negro gold project in Argentina l onore and Cochenour gold projects in Canada, the El Morro gold/copper project (70% interest) in Chile and the Camino Rojo gold/silver projects in Mexico.
Goldcorp Inc. (GG)‘s Financial Outlook
The 21 analysts offering 12-month price forecasts for Goldcorp Inc have a median target of 18.00, with a high estimate of 22.00 and a low estimate of 14.10. The median estimate represents a +33.23% increase from the last price of 13.51.
According to Zacks Investment Research, Goldcorp Inc. has a Consensus Recommendation of 1.77. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock declined-1.89% and closed its last trading session at $13.51. The company has the market capitalization of $11.77 Billion. The firm touched its 52-Week high on Obsolete and 52-Week low on Obsolete. The company has volume of 5.14 Million shares. The company has a total of 871 Million shares outstanding.
Goldcorp Inc. (GG) in the last quarter reported its actual EPS of $0.1/share. The difference between the actual and Estimated EPS is $-0.01. This shows a surprise factor of -9.1 percent.
The company has YTD performance of 5.79 percent. Beta for Goldcorp Inc. stands at 0.11 while its ATR (average true range) is 0.35. The company has Weekly Volatility of 2.39%% and Monthly Volatility of 2.37%.
Goldcorp Inc. has distance from 20-day Simple Moving Average (SMA20) of 2.35%, Distance from 50-Day Simple Moving Average of SMA50 percent and Distance from 200-Day Simple Moving Average of 2.4%.
The Company currently has ROA (Return on Assets) of 3 percent, Return on Equity (ROE) of 4.7 Percent and Return on Investment (ROI) of 5.9% with Gross margin of 15.9 percent and Operating & Profit margin of 16.1% and 19.2% respectively.